Herpes Zoster, Hepatitis C, and Tuberculosis Risk with Apremilast Compared to Biologics, DMARDs and Corticosteroids to Treat Psoriasis and Psoriatic Arthritis

Katrina Wilcox Hagberg,1 Rebecca Persson,1 Catherine Vasilakis-Scaramozza,1 Steve Niemcryk,2 Michael Peng,2 Maria Paris,2 Anders Lindholm,2 Susan Jick1,3 1Boston Collaborative Drug Surveillance Program, Lexington, MA 02421, USA; 2Celgene Corporation, Summit, NJ 07901, USA; 3Boston University School...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Hagberg KW, Persson R, Vasilakis-Scaramozza C, Niemcryk S, Peng M, Paris M, Lindholm A, Jick S
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2020-02-01
Cyfres:Clinical Epidemiology
Pynciau:
apremilast
psoriasis
psoriatic arthritis
herpes zoster
hepatitis c
tuberculosis
Mynediad Ar-lein:https://www.dovepress.com/herpes-zoster-hepatitis-c-and-tuberculosis-risk-with-apremilast-compar-peer-reviewed-article-CLEP
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg